Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...

Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

Natco Pharma announced approval of its ANDA for Everolimus tablets for oral suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation. NATCO's ...

NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.

The Federal Reserve is expected to keep interest rates on hold on Wednesday. Plus, earnings reports from Apple, General ...

and seizures in tuberous sclerosis complex (TSC), along with PDE10a inhibitor gemlapodect (NOE-105) in a phase 2b study in Tourette's syndrome, and NOE-115, a broad-spectrum monoamine modulator in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...